FDA Approved: DROXIDOPA — Original Application (ScieGen Pharmaceuticals Inc)

View source ↗

Summary

FDA approved the original application for droxidopa from ScieGen Pharmaceuticals Inc to treat symptomatic neurogenic orthostatic hypotension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Orthostatic Hypotension

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

ORIG AP for DROXIDOPA (DROXIDOPA)